# Comparison of a TauroLock™ Based Regimen to 4% Citrate as Lock Solution in Tunneled Haemodialysis Catheters for the Prevention of Bacteraemia and Dysfunction

> **NCT02789501** · PHASE4 · COMPLETED · sponsor: **Medical University of Vienna** · enrollment: 106 (actual)

## Conditions studied

- Catheter Infections
- End-stage Renal Disease

## Interventions

- **DEVICE:** 4% citrate lock solution regimen
- **DEVICE:** TauroLock lock solution regimen

## Key facts

- **NCT ID:** NCT02789501
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2016-08
- **Final completion:** —
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2016-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02789501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02789501, "Comparison of a TauroLock™ Based Regimen to 4% Citrate as Lock Solution in Tunneled Haemodialysis Catheters for the Prevention of Bacteraemia and Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02789501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*